ArticleCommunications chemistry2025
Identification, characterization, and structure-activity relationship of the ASIC3-selective peptide WRPRFa.
Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gene arrangement within concatemeric constructs governs the functional divergence of human and rat ASIC3 concatemers.Journal of physiology and biochemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acid-sensing ion channels (ASICs) are proton-gated cation channels that detect and signal increases in proton concentration. ASIC1a and ASIC3 play a role in pain sensation associated with extracellular acidification. There are few selective modulators of ASIC3, including the tetrapeptide RFamide RPRFa, which slows the acute desensitization of ASIC3. Here we describe the peptide WRPRFa as the most potent ASIC3 activator to date and a more effective pharmacological tool. WRPRFa enhances the pH sensitivity of ASIC3 and effectively removes acute desensitization. Additionally, we demonstrate that ASIC3 can undergo tachyphylaxis at very acidic pH, which is accelerated by WRPRFa. Our work characterizes a selective and effective in vitro tool to study the interaction of RFamides and ASICs, and by extension gating mechanisms of ASIC3.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.